Filmmaker Christopher Nolan has reportedly earned $72 million (Rs 595 cr) for the gigantic success of his last film, Oppenheimer, putting him in the same bracket as some of the biggest movie stars in the world. According to a report in Forbes, Nolan actually earned a gross total of $85 million for the film, but after deducting his agents and lawyers’ fees, the figure would come to around $72 million. Oppenheimer, which was released last year, made $957 million at the global box office; that’s nearly Rs 8000 crore.
According to the publication, Universal agreed to give the filmmaker “15 percent of first-dollar gross” on Oppenheimer, which meant that Nolan got a share of every penny that the movie earned before the studio recovered its expenses. The initial ask from Nolan was of 20 percent, which was brought down 15, with the remaining five percent going to producer and Nolan’s wife Emma Thomas.
Tom Cruise reportedly got 12.5 percent of first-dollar gross for Mission: Impossible-Dead Reckoning Part One, which released just days before Oppenheimer.
Indiewire explained that Nolan, in order to keep the movie’s budget under $100 million, also reduced his directing, writing, and producing fees so he could “maximize what he earned on the back end.” Nolan’s pay cheque for the film includes what he would earn from home video sales and streaming licensing. Oppenheimer marked Nolan’s first film with Universal, after he severed ties with longtime partners Warner Bros, in protest of the studio’s controversial 2021 decision to release every film on its slate simultaneously on streaming. A bidding war to sign Nolan’s services ensued, with Universal winning out.
Oppenheimer has been nominated in 13 categories at the upcoming Oscars. Nolan is nominated in the Best Director, Best Original Screenplay and Best Picture category.
Click for more updates and latest Hollywood News along with Bollywood and Entertainment updates. Also get latest news and top headlines from India and around the World at The Indian Express.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
